Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Health Care Sector · Mutual

LYFAX Expense Ratio & Fees

Ticker LYFAX · Since 2019-11-29 · · Holdings as of Jun 30, 2026

Expense ratio
1.66%$166/yr per $10k
5-yr return
+4.1%annualized
1-yr return
+20.6%as of Dec 2025
Net assets
$46.6Mall share classes
Holdings
62

Bottom line

What is LYFAX's expense ratio?

LYFAX's expense ratio is 1.66%, or about $166 a year on every $10,000 invested. That is more expensive than 86% of health care sector funds we track (median 0.96%). This share class also charges a front-end sales load of up to 5.75%, taken from your investment when you buy. Its expense ratio includes a 0.25% 12b-1 marketing fee.

Updated Jul 28, 2026

LYFAX fee table

Net expense ratio1.66%
Gross expense ratio2.33%
Management fee1.25%
12b-1 (distribution) fee0.25%
Other expenses0.82%
Acquired fund fees0.01%
Fee waiver / reimbursement-0.67%
Max front-end sales load5.75%
Max deferred sales charge1%
Redemption fee0%

Source: Fund prospectus fee table, filed Jul 28, 2026

What LYFAX costs in dollars

The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:

1 year3 years5 years10 years
LYFAX$734$1,200$1,691$3,039

Source: Fund prospectus expense example

The long-run cost of fees

On $100,000 growing at 6% a year for 20 years, a 1.66% expense ratio costs roughly $86,800 in lost growth, versus about $53,400 for the median health care sector fund (0.96%).

Cheapest way to own AlphaCentric Life Sciences and Healthcare Fund

All share classes
TickerClassExpense ratioFront load
LYFIXAlphaCentric Life Sciences and Healthcare Fund Class I1.41%0%
LYFAXAlphaCentric Life Sciences and Healthcare Fund Class A1.66%5.75%
LYFCXAlphaCentric Life Sciences and Healthcare Fund Class C2.41%0%